Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (421-430 of 489) with videos related to

Pageof 49
Sort By:
Plos One|May 26, 2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease riskMuhammad Ali, Yun Ju Sung, Fengxian Wang, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2014
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchSid E O'Bryant, Veer Gupta, Kim Henriksen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from <i>GRN</i> gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
The Lancet. Neurology|November 10, 2012
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyEric M Reiman, Yakeel T Quiroz, Adam S Fleisher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2017
Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's diseaseBelinda M Brown, Hamid R Sohrabi, Kevin Taddei, et al.
JAMA Neurology|November 12, 2019
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical TrialRichard M Tsai, Zachary Miller, Mary Koestler, et al.
Pageof 49

Showing results (421-430 of 489) with videos related to

Sort By:
Pageof 49
Plos One|May 26, 2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease riskMuhammad Ali, Yun Ju Sung, Fengxian Wang, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2014
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchSid E O'Bryant, Veer Gupta, Kim Henriksen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from <i>GRN</i> gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
The Lancet. Neurology|November 10, 2012
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyEric M Reiman, Yakeel T Quiroz, Adam S Fleisher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2017
Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's diseaseBelinda M Brown, Hamid R Sohrabi, Kevin Taddei, et al.
JAMA Neurology|November 12, 2019
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical TrialRichard M Tsai, Zachary Miller, Mary Koestler, et al.
Pageof 49